What Makes an Opportunity Ownable?
The KØDE lens for deciding when a health & life sciences opportunity is worth building, backing and ultimately owning for the long term.

Key takeaways
No single metric defines a good opportunity. Ownership fit is distinct from investment attractiveness. Management and economics matter. The lens is qualitative, not a public score.
Attractive markets are easy to find.
Attractive ownership opportunities are not.
A category can be growing quickly and still contain weak businesses. A company can have an impressive product and still lack durable economics. A founder can identify a real problem while the surrounding market remains too fragmented, too capital-intensive or too difficult to access.
For KØDE, the relevant question is therefore not simply:
Is this interesting?
It is:
Is there something here worth building, backing and ultimately owning?
We call that ownability.
Ownability is not a single financial metric. It is the combination of market need, business quality, operating feasibility and ownership logic that makes long-term participation rational.
Structural Change Comes Before the Company
KØDE begins with structural change.
What is changing in health?
How are consumers behaving differently?
Where are existing systems becoming inadequate?
Which capabilities are becoming more important?
Where is activity moving—from institution to consumer, from episodic treatment to ongoing health management, from isolated services to more integrated systems?
Structural change matters because good companies are often built around persistent shifts rather than temporary enthusiasm.
But a growing market alone does not create an ownership opportunity.
The first test is therefore whether the change is sufficiently durable to create a problem worth solving.
If the underlying need disappears when attention moves elsewhere, the opportunity may be fashionable.
It is unlikely to be ownable.
There Must Be a Real Customer Problem
Every durable business begins with demand.
Not theoretical demand.
Not market-size slides.
Not enthusiasm from industry observers.
A customer must have a problem important enough to change behaviour or spend money.
In health and life sciences, that customer can take different forms.
It may be a consumer.
A provider.
A health organisation.
A research institution.
A commercial partner.
An employer.
A property owner.
Or another company somewhere in the health value chain.
The structure varies, but the principle does not.
There must be a credible economic customer.
This distinction is especially important in health, where social importance and business viability are not automatically the same thing.
A problem can be medically meaningful and still lack a workable payment model.
A product can be scientifically interesting and still fail to reach customers economically.
Ownability begins where relevance and willingness to pay meet.
The Economics Must Work at Company Level
A compelling mission does not compensate for poor economics.
KØDE therefore asks whether the opportunity can become a fundamentally sound business.
That requires understanding how revenue is generated, what it costs to acquire and serve customers, what gross or contribution economics look like, how much capital is required and whether the model improves as the company grows.
Different businesses require different economic structures.
A consumer-health product behaves differently from a diagnostics platform.
A multi-site health business behaves differently from software.
A health-infrastructure company behaves differently from all three.
There is no universal margin or growth threshold.
The important question is whether the underlying economics support the business model being proposed.
Growth is useful.
Economic quality is more important.
Route to Market Must Be Credible
Many good health products fail commercially.
The reason is often not the product.
It is access.
Who sells it?
Through which channel?
At what cost?
Who already has the customer relationship?
How difficult is market entry?
Can distribution be defended?
Does the company control its route to market or remain dependent on parties with stronger bargaining power?
For KØDE, distribution is not an afterthought.
It can be one of the defining assets of the business.
This is particularly important in Consumer Health, diagnostics and international market entry, where the ability to reach customers can be more difficult to build than the product itself.
An opportunity becomes more ownable when customer access can become durable rather than permanently rented.
The Business Needs a Reason to Become Stronger Over Time
A company worth owning should have some mechanism through which duration improves its position.
That does not necessarily mean technology patents or conventional barriers to entry.
Defensibility can emerge from different sources:
customer trust,
distribution,
data,
brand,
specialist knowledge,
operating capability,
physical infrastructure,
regulatory credibility,
location density,
network relationships,
switching costs,
or combinations of these.
The relevant question is not whether competitors can theoretically enter the market.
They usually can.
The question is whether the company can become materially harder to displace as it develops.
A business that resets to zero every year may generate revenue.
It is less likely to compound.
Management Must Be Possible
Some opportunities look attractive until somebody asks who will actually run the company.
Every ownership thesis eventually becomes a leadership question.
Is there a credible founder?
Is an experienced operator already involved?
Can a suitable leader realistically be recruited?
Does the business require specialist expertise that is difficult to assemble?
Can accountability be placed clearly with one person or one management team?
This matters particularly in company building.
An opportunity without leadership is not yet a company.
KØDE may participate in validation, formation, governance and capability building, but there must ultimately be accountable management responsible for operating performance.
Ownability therefore includes manageability.
If the business cannot credibly be led, it is not ready to be owned.
Operating Complexity Must Be Understood
Complexity is not automatically negative.
Some of the most valuable health businesses are operationally difficult.
But complexity must create something worth the effort.
Health infrastructure may require property, service design, staffing, technology and commercial systems to work together.
Health systems may require coordination across multiple providers and stakeholders.
Consumer health may combine regulation, evidence, brand, distribution and repeat customer behaviour.
The important distinction is between necessary complexity and accidental complexity.
Necessary complexity can create barriers and capability advantages.
Accidental complexity simply makes a weak business harder to run.
KØDE therefore asks whether the operating system of the company can become coherent enough to scale.
Ownership Must Add Something
This is the test that separates business quality from ownership fit.
A company can be excellent and still provide no compelling reason for KØDE to participate.
Why should KØDE be involved?
Can we contribute to the formation of the company?
Can we help create a route to market?
Can ownership architecture unlock an opportunity?
Can operating capability materially strengthen the business?
Can KØDE bring together assets, people or capabilities that are currently fragmented?
Can long-term ownership support decisions that a shorter-term structure would make more difficult?
If the answer to those questions is no, there may be no reason for KØDE to own the opportunity.
That is not a criticism of the company.
It is discipline.
Capital Intensity Must Match the Opportunity
Some businesses require little capital to begin.
Others require significant investment before the economics become visible.
Neither structure is inherently better.
The relevant question is whether the amount, timing and risk of capital required are justified by the potential quality of the resulting business.
A capital-intensive model may be highly ownable if the infrastructure itself becomes strategic and difficult to reproduce.
A capital-light model may be unattractive if customer acquisition remains permanently expensive and little defensibility accumulates.
KØDE therefore does not treat capital efficiency as an ideology.
Capital is one input into the ownership equation.
It has to make sense relative to what is being created.
There Must Be a Reason to Hold
The final test is duration.
Why would this company still be worth owning years from now?
That question changes the analysis.
It directs attention away from short-term market excitement and toward the qualities that persist:
customer relevance,
economics,
leadership,
strategic position,
institutional capability,
and the ability to adapt.
KØDE is interested in businesses where long-term ownership can remain rational even after the original company-building thesis has been proven.
Because the objective is not simply to create something that can be sold.
The stronger ambition is to create something that does not need to be sold in order for ownership to make sense.
Ownability Is a Decision, Not a Score
It is tempting to turn these questions into a numerical framework.
That creates the appearance of precision.
It can also obscure judgment.
KØDE does not need a public 100-point investment score.
Ownability is a decision made from several connected questions:
Is the structural change real?
Is the customer problem meaningful?
Can the economics work?
Is there a credible route to market?
Can defensibility accumulate?
Can accountable management be established?
Can the operating complexity be mastered?
Is there a reason for KØDE to participate?
Is the required capital justified?
Is there a reason to own the business for the long term?
None of these questions works in isolation.
Together, they create conviction.
From Interesting to Ownable
KØDE will encounter more opportunities than it should pursue.
That is healthy.
A venture and ownership company should not be measured by how many ideas it can generate.
It should be measured by the quality of what it chooses to build and own.
The progression is therefore deliberate:
FIND structural change.
VALIDATE whether a real opportunity exists.
BUILD where a company needs to be created.
OPERATE where capability is required.
OWN where long-term participation is justified.
COMPOUND what the company and the institution learn.
The most important transition in that sequence is not from idea to company.
It is from interesting to ownable.
Because ownership should never be the default outcome.
It should be the result of conviction.